financetom
Business
financetom
/
Business
/
Update: Best Buy's Shares Rise After Higher Fiscal Q2 Non-GAAP Earnings, Raises Fiscal 2025 Non-GAAP EPS Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Best Buy's Shares Rise After Higher Fiscal Q2 Non-GAAP Earnings, Raises Fiscal 2025 Non-GAAP EPS Guidance
Aug 29, 2024 8:46 AM

11:16 AM EDT, 08/29/2024 (MT Newswires) -- (Updates with the latest stock movement in the headline and the first paragraph.)

Best Buy ( BBY ) shares rose 16% in recent Thursday trading after the consumer electronics retailer reported higher fiscal Q2 non-GAAP earnings per diluted share from a year earlier and raised its fiscal 2025 non-GAAP diluted EPS guidance.

The company reported fiscal Q2 adjusted earnings of $1.34 per diluted share, up from $1.22 a year earlier.

Analysts polled by Capital IQ expected $1.16.

Revenue for the quarter ended Aug. 3 was $9.29 billion, compared with $9.58 billion a year earlier.

Analysts surveyed by Capital IQ expected $9.25 billion.

The company said it expects fiscal-year 2025 adjusted earnings of $6.10 to $6.35 per diluted share, compared with $5.75 to $6.20 previously. Analysts polled by Capital IQ expect $6.10.

The company expects revenue for the year of $41.3 billion to $41.9 billion, compared with prior guidance of $41.3 billion to $42.6 billion. Analysts surveyed by Capital IQ expect $41.79 billion.

The company also maintained a quarterly cash dividend of $0.94 per common share, payable on Oct. 10 to shareholders of record on Sept. 19.

Price: 102.07, Change: +14.28, Percent Change: +16.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Phio Pharmaceuticals Stock Soaring Today?
Why Is Phio Pharmaceuticals Stock Soaring Today?
Nov 3, 2025
Shares of Phio Pharmaceuticals Corp. ( PHIO ) are rising Monday after the company provided an update on an ongoing medical trial. PHIO is charging ahead with explosive momentum. Track the action here. What To Know: Clinical-stage siRNA biopharmaceutical company Phio Pharmaceuticals announced the pathologic results for three patients with cutaneous squamous cell carcinoma (cSCC) who completed treatment in the fifth and...
TAYLOR FARMS ACQUIRES NATURES WAY FOODS
TAYLOR FARMS ACQUIRES NATURES WAY FOODS
Nov 3, 2025
Leading North American producer of salads to expand into United Kingdom SALINAS, Calif., Nov. 3, 2025 /PRNewswire/ -- Taylor Farms today announced the acquisition of Natures Way Foods, one of the United Kingdom's leading fresh prepared food manufacturers. Based in Chichester, England, Natures Way Foods employs 1,300 people and specializes in the supply of fresh, convenient food supporting retail and...
WellStar $62 Million Financing Shores Up Growth Capital Ahead of Expected 2026 IPO
WellStar $62 Million Financing Shores Up Growth Capital Ahead of Expected 2026 IPO
Nov 3, 2025
01:19 PM EST, 11/03/2025 (MT Newswires) -- WELL Health Technologies ( WHTCF ) announced a $62 million Series B financing and private round for Wellstar, led by institutional investors, Mawer, Edgepoint and Picton. Wellstar is the healthcare SaaS platform within WELL, last disclosed generating +$70 million sales (80-90% recurring), 25% adj. EBITDA margins and growing at +20%, Stifel Canada notes....
Boqii Shares Rise After $4.2 Million Registered Direct Offering
Boqii Shares Rise After $4.2 Million Registered Direct Offering
Nov 3, 2025
01:21 PM EST, 11/03/2025 (MT Newswires) -- Boqii ( BQ ) shares jumped 21.8% in recent trading Monday after the company announced a registered direct offering expected to raise $4.2 million in gross proceeds. Under the offering, Boqii ( BQ ) will sell 1.5 million class A shares or pre-funded warrants at $2.80 per share, with the warrants exercisable at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved